Hepatitis C virus in fulminant hepatic failure.

Reactivation of precore mutant hepatitis B virus leading to fulminant hepatic failure following cytotoxic treatment.

Hepatic regeneration: implications in fulminant hepatic failure.

Sulfasalazine-induced fulminant hepatic failure.

Orlistat-induced fulminant hepatic failure.

A case of fulminant liver failure associated with hepatitis C virus.

Multimodal brain monitoring in fulminant hepatic failure.

Plasma prostaglandins in fulminant hepatic failure.

Artificial liver support in fulminant hepatic failure.

Haemofiltration in patients with fulminant hepatic failure.

The brain in fulminant hepatic failure.

New therapeutic aspects in fulminant hepatic failure.

Pharmacokinetics of flumazenil in fulminant hepatic failure.

Continuous haemoperfusion for fulminant hepatic failure.

Pathogenesis of renal failure in cirrhosis and fulminant hepatic failure.

Heroic treatment for fulminant hepatic failure?

Animal models of fulminant hepatic failure.

Fulminant hepatic failure secondary to primary hepatic angiosarcoma.

Disseminated Herpes Simplex Virus with Fulminant Hepatitis.

Clinical differentiation of fulminant Wilsonian hepatitis from other causes of hepatic failure.

Cytokine profiles and hepatic injury in occult hepatitis C versus chronic hepatitis C virus infection.

Fulminant hepatic failure of autoimmune aetiology in children.

Intestinal dendritic cells change in number in fulminant hepatic failure.

Fulminant hepatic failure in the context of reinstituting valproate use.

Elevated brain concentrations of 1,4-benzodiazepines in fulminant hepatic failure.

Suggest Documents

Reactivation of precore mutant hepatitis B virus leading to fulminant hepatic failure following cytotoxic treatment.

Hepatic regeneration: implications in fulminant hepatic failure.

Sulfasalazine-induced fulminant hepatic failure.

Orlistat-induced fulminant hepatic failure.

A case of fulminant liver failure associated with hepatitis C virus.

Multimodal brain monitoring in fulminant hepatic failure.

Plasma prostaglandins in fulminant hepatic failure.

Artificial liver support in fulminant hepatic failure.

Haemofiltration in patients with fulminant hepatic failure.

The brain in fulminant hepatic failure.

New therapeutic aspects in fulminant hepatic failure.

Pharmacokinetics of flumazenil in fulminant hepatic failure.

Continuous haemoperfusion for fulminant hepatic failure.

Pathogenesis of renal failure in cirrhosis and fulminant hepatic failure.

Heroic treatment for fulminant hepatic failure?

Animal models of fulminant hepatic failure.

Fulminant hepatic failure secondary to primary hepatic angiosarcoma.

Disseminated Herpes Simplex Virus with Fulminant Hepatitis.

Clinical differentiation of fulminant Wilsonian hepatitis from other causes of hepatic failure.

Cytokine profiles and hepatic injury in occult hepatitis C versus chronic hepatitis C virus infection.

Fulminant hepatic failure of autoimmune aetiology in children.

Intestinal dendritic cells change in number in fulminant hepatic failure.

Fulminant hepatic failure in the context of reinstituting valproate use.

Elevated brain concentrations of 1,4-benzodiazepines in fulminant hepatic failure.

Hepatitis C virus in fulminant hepatic failure.

Recommend Documents

Follow Us